Review



rabbit monoclonal anti proliferating cell nuclear antigen pcna  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Proteintech rabbit monoclonal anti proliferating cell nuclear antigen pcna
    hfNCSC-sEVs are taken up by PCs in vitro and enhance their proliferation and migration. (A) Primary cultures of hfNCSCs were established from male Sprague–Dawley rats. (B) Immunofluorescence staining of the neural crest cell marker p75 (red) and the stem cell marker nestin (green) in hfNCSCs, with 4′,6-diamidino-2-phenylindole (DAPI) staining indicating the nuclei. (C) Western blot analysis demonstrated the presence of surface markers (cluster of differentiation [CD]9, CD81, and tumor susceptibility gene 101 protein [TSG101]) and the absence of an endoplasmic reticulum marker (calnexin) in hfNCSC-sEVs. (D) Nanoparticle tracking analysis was used to quantify the concentration and size distribution of hfNCSC-sEVs. (E) Transmission electron microscopy was used to visualize the characteristic morphology of hfNCSC-sEVs. (F) Immunofluorescence staining indicated that the third-generation PCs cultured in vitro were positive for claudin-1, zonula occludens 1 (ZO1), and glucose transporter 1 (GLUT1) but negative for S100, with DAPI staining marking the nuclei. (G) The internalization of PKH26-labeled hfNCSC-sEVs (red) by ZO1-positive PCs (green) was visualized using immunofluorescence staining, with DAPI staining to mark the nuclei. (H) The Cell Counting Kit-8 assay was used to evaluate the cell viability of PCs across concentrations of 0, 2 × 10 8 , 5 × 10 8 , and 10 × 10 8 particles/mL hfNCSC-sEVs at 3, 5, and 7 days of in vitro culture ( n = 5 per group). (I) The Transwell assay was used to quantify the number of migrating PCs at 6, 12, and 18 hours post-treatment with the aforementioned concentrations of hfNCSC-sEVs, in in vitro culture ( n = 6 per group). (J) Western blot and (K) statistical analyses revealed the relative protein expression levels of proliferating cell nuclear antigen <t>(PCNA)</t> and vimentin in PCs from the phosphate-buffered saline (PBS) and hfNCSC-sEVs groups on day 5 of in vitro culture (normalized to β-actin, n = 3 per group). Data are expressed as the mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001 (one-way analysis of variance and Tukey’s multiple comparison test for H and I; Student’s t -test for K). The data were from at least three separate and independent studies. CCK-8: Cell counting kit-8; GLUT1: glucose transporter 1; hfNCSCs: hair follicle neural crest stem cells; ns: not significant; PCNA: proliferating cell nuclear antigen; PCs: perineurial cells; sEVs: small extracellular vesicles; ZO1: zonula occludens 1.
    Rabbit Monoclonal Anti Proliferating Cell Nuclear Antigen Pcna, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1184 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit monoclonal anti proliferating cell nuclear antigen pcna/product/Proteintech
    Average 96 stars, based on 1184 article reviews
    rabbit monoclonal anti proliferating cell nuclear antigen pcna - by Bioz Stars, 2026-02
    96/100 stars

    Images

    1) Product Images from "Small extracellular vesicles derived from hair follicle neural crest stem cells enhance perineurial cell proliferation and migration via the TGF-β/SMAD/HAS2 pathway"

    Article Title: Small extracellular vesicles derived from hair follicle neural crest stem cells enhance perineurial cell proliferation and migration via the TGF-β/SMAD/HAS2 pathway

    Journal: Neural Regeneration Research

    doi: 10.4103/NRR.NRR-D-25-00127

    hfNCSC-sEVs are taken up by PCs in vitro and enhance their proliferation and migration. (A) Primary cultures of hfNCSCs were established from male Sprague–Dawley rats. (B) Immunofluorescence staining of the neural crest cell marker p75 (red) and the stem cell marker nestin (green) in hfNCSCs, with 4′,6-diamidino-2-phenylindole (DAPI) staining indicating the nuclei. (C) Western blot analysis demonstrated the presence of surface markers (cluster of differentiation [CD]9, CD81, and tumor susceptibility gene 101 protein [TSG101]) and the absence of an endoplasmic reticulum marker (calnexin) in hfNCSC-sEVs. (D) Nanoparticle tracking analysis was used to quantify the concentration and size distribution of hfNCSC-sEVs. (E) Transmission electron microscopy was used to visualize the characteristic morphology of hfNCSC-sEVs. (F) Immunofluorescence staining indicated that the third-generation PCs cultured in vitro were positive for claudin-1, zonula occludens 1 (ZO1), and glucose transporter 1 (GLUT1) but negative for S100, with DAPI staining marking the nuclei. (G) The internalization of PKH26-labeled hfNCSC-sEVs (red) by ZO1-positive PCs (green) was visualized using immunofluorescence staining, with DAPI staining to mark the nuclei. (H) The Cell Counting Kit-8 assay was used to evaluate the cell viability of PCs across concentrations of 0, 2 × 10 8 , 5 × 10 8 , and 10 × 10 8 particles/mL hfNCSC-sEVs at 3, 5, and 7 days of in vitro culture ( n = 5 per group). (I) The Transwell assay was used to quantify the number of migrating PCs at 6, 12, and 18 hours post-treatment with the aforementioned concentrations of hfNCSC-sEVs, in in vitro culture ( n = 6 per group). (J) Western blot and (K) statistical analyses revealed the relative protein expression levels of proliferating cell nuclear antigen (PCNA) and vimentin in PCs from the phosphate-buffered saline (PBS) and hfNCSC-sEVs groups on day 5 of in vitro culture (normalized to β-actin, n = 3 per group). Data are expressed as the mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001 (one-way analysis of variance and Tukey’s multiple comparison test for H and I; Student’s t -test for K). The data were from at least three separate and independent studies. CCK-8: Cell counting kit-8; GLUT1: glucose transporter 1; hfNCSCs: hair follicle neural crest stem cells; ns: not significant; PCNA: proliferating cell nuclear antigen; PCs: perineurial cells; sEVs: small extracellular vesicles; ZO1: zonula occludens 1.
    Figure Legend Snippet: hfNCSC-sEVs are taken up by PCs in vitro and enhance their proliferation and migration. (A) Primary cultures of hfNCSCs were established from male Sprague–Dawley rats. (B) Immunofluorescence staining of the neural crest cell marker p75 (red) and the stem cell marker nestin (green) in hfNCSCs, with 4′,6-diamidino-2-phenylindole (DAPI) staining indicating the nuclei. (C) Western blot analysis demonstrated the presence of surface markers (cluster of differentiation [CD]9, CD81, and tumor susceptibility gene 101 protein [TSG101]) and the absence of an endoplasmic reticulum marker (calnexin) in hfNCSC-sEVs. (D) Nanoparticle tracking analysis was used to quantify the concentration and size distribution of hfNCSC-sEVs. (E) Transmission electron microscopy was used to visualize the characteristic morphology of hfNCSC-sEVs. (F) Immunofluorescence staining indicated that the third-generation PCs cultured in vitro were positive for claudin-1, zonula occludens 1 (ZO1), and glucose transporter 1 (GLUT1) but negative for S100, with DAPI staining marking the nuclei. (G) The internalization of PKH26-labeled hfNCSC-sEVs (red) by ZO1-positive PCs (green) was visualized using immunofluorescence staining, with DAPI staining to mark the nuclei. (H) The Cell Counting Kit-8 assay was used to evaluate the cell viability of PCs across concentrations of 0, 2 × 10 8 , 5 × 10 8 , and 10 × 10 8 particles/mL hfNCSC-sEVs at 3, 5, and 7 days of in vitro culture ( n = 5 per group). (I) The Transwell assay was used to quantify the number of migrating PCs at 6, 12, and 18 hours post-treatment with the aforementioned concentrations of hfNCSC-sEVs, in in vitro culture ( n = 6 per group). (J) Western blot and (K) statistical analyses revealed the relative protein expression levels of proliferating cell nuclear antigen (PCNA) and vimentin in PCs from the phosphate-buffered saline (PBS) and hfNCSC-sEVs groups on day 5 of in vitro culture (normalized to β-actin, n = 3 per group). Data are expressed as the mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001 (one-way analysis of variance and Tukey’s multiple comparison test for H and I; Student’s t -test for K). The data were from at least three separate and independent studies. CCK-8: Cell counting kit-8; GLUT1: glucose transporter 1; hfNCSCs: hair follicle neural crest stem cells; ns: not significant; PCNA: proliferating cell nuclear antigen; PCs: perineurial cells; sEVs: small extracellular vesicles; ZO1: zonula occludens 1.

    Techniques Used: In Vitro, Migration, Immunofluorescence, Staining, Marker, Western Blot, Concentration Assay, Transmission Assay, Electron Microscopy, Cell Culture, Labeling, Cell Counting, Transwell Assay, Expressing, Saline, Comparison, CCK-8 Assay

    miR-21-5p in hfNCSC-sEVs augments cell proliferation and migration by enhancing HAS2 expression in PCs. (A, B) Western blot (A) and statistical analyses (B) revealed the relative protein expression levels of HAS2, proliferating cell nuclear antigen (PCNA), and vimentin in PCs across the –/–, –/si- Has2 , hfNCSC-sEVs/–, and hfNCSC-sEVs/si- Has2 groups on day 5 of in vitro culture (normalized to β-actin, n = 3 per group). (C, D) The wound healing assay (C) and statistical analysis (D) demonstrated the migration rates of PCs in the aforementioned groups ( n = 3 per group). (E) The Cell Counting Kit-8 assay was used to assess cell viability in PCs across the same groups on day 5 of in vitro culture ( n = 5 per group). (F, G) Western blot (F) and statistical analyses (G) indicated the relative protein expression levels of HAS2, PCNA, and vimentin in PCs treated with phosphate-buffered saline (PBS), hfNCSC-sEVs, or hfNCSC-sEVs + miR-21-5p inhibitor on day 5 of in vitro culture (normalized to β-actin, n = 3 per group). (H–J) Immunofluorescence staining visualized the expression of HAS2 (red) and 5-ethynyl-2′-deoxyuridine (EdU; green) in PCs (H), and statistical analysis revealed the integrated optical density (IOD) of zonula occludens 1 (ZO1; I) and the cell proliferation rates (J) in the PBS, hfNCSC-sEVs, and hfNCSC-sEVs + miR-21-5p inhibitor groups on day 5 of in vitro culture ( n = 3 per group). (K, L) Western blot (K) and statistical analyses (L) showed the relative protein expression levels of HAS2, PCNA, and vimentin in regenerated tissue from the PBS, hfNCSC-sEVs, and hfNCSC-sEVs + miR-21-5p inhibitor groups on day 5 post-operation (normalized to β-tubulin, n = 3 per group). Data are expressed as the mean ± SEM. ** P < 0.01, *** P < 0.001 (one-way analysis of variance and Tukey’s multiple comparison test for B, D, E, G, I, J, and L). The data were from at least three separate and independent studies. CCK-8: Cell counting kit-8; EdU: 5-ethynyl-2′-deoxyuridine; HAS2: hyaluronan synthase 2; hfNCSCs: hair follicle neural crest stem cells; IOD: integrated optical density; PCNA: proliferating cell nuclear antigen; PCs: perineurial cells; sEVs: small extracellular vesicles; ZO1: zonula occludens 1.
    Figure Legend Snippet: miR-21-5p in hfNCSC-sEVs augments cell proliferation and migration by enhancing HAS2 expression in PCs. (A, B) Western blot (A) and statistical analyses (B) revealed the relative protein expression levels of HAS2, proliferating cell nuclear antigen (PCNA), and vimentin in PCs across the –/–, –/si- Has2 , hfNCSC-sEVs/–, and hfNCSC-sEVs/si- Has2 groups on day 5 of in vitro culture (normalized to β-actin, n = 3 per group). (C, D) The wound healing assay (C) and statistical analysis (D) demonstrated the migration rates of PCs in the aforementioned groups ( n = 3 per group). (E) The Cell Counting Kit-8 assay was used to assess cell viability in PCs across the same groups on day 5 of in vitro culture ( n = 5 per group). (F, G) Western blot (F) and statistical analyses (G) indicated the relative protein expression levels of HAS2, PCNA, and vimentin in PCs treated with phosphate-buffered saline (PBS), hfNCSC-sEVs, or hfNCSC-sEVs + miR-21-5p inhibitor on day 5 of in vitro culture (normalized to β-actin, n = 3 per group). (H–J) Immunofluorescence staining visualized the expression of HAS2 (red) and 5-ethynyl-2′-deoxyuridine (EdU; green) in PCs (H), and statistical analysis revealed the integrated optical density (IOD) of zonula occludens 1 (ZO1; I) and the cell proliferation rates (J) in the PBS, hfNCSC-sEVs, and hfNCSC-sEVs + miR-21-5p inhibitor groups on day 5 of in vitro culture ( n = 3 per group). (K, L) Western blot (K) and statistical analyses (L) showed the relative protein expression levels of HAS2, PCNA, and vimentin in regenerated tissue from the PBS, hfNCSC-sEVs, and hfNCSC-sEVs + miR-21-5p inhibitor groups on day 5 post-operation (normalized to β-tubulin, n = 3 per group). Data are expressed as the mean ± SEM. ** P < 0.01, *** P < 0.001 (one-way analysis of variance and Tukey’s multiple comparison test for B, D, E, G, I, J, and L). The data were from at least three separate and independent studies. CCK-8: Cell counting kit-8; EdU: 5-ethynyl-2′-deoxyuridine; HAS2: hyaluronan synthase 2; hfNCSCs: hair follicle neural crest stem cells; IOD: integrated optical density; PCNA: proliferating cell nuclear antigen; PCs: perineurial cells; sEVs: small extracellular vesicles; ZO1: zonula occludens 1.

    Techniques Used: Migration, Expressing, Western Blot, In Vitro, Wound Healing Assay, Cell Counting, Saline, Immunofluorescence, Staining, Comparison, CCK-8 Assay



    Similar Products

    96
    Proteintech rabbit monoclonal anti proliferating cell nuclear antigen pcna
    hfNCSC-sEVs are taken up by PCs in vitro and enhance their proliferation and migration. (A) Primary cultures of hfNCSCs were established from male Sprague–Dawley rats. (B) Immunofluorescence staining of the neural crest cell marker p75 (red) and the stem cell marker nestin (green) in hfNCSCs, with 4′,6-diamidino-2-phenylindole (DAPI) staining indicating the nuclei. (C) Western blot analysis demonstrated the presence of surface markers (cluster of differentiation [CD]9, CD81, and tumor susceptibility gene 101 protein [TSG101]) and the absence of an endoplasmic reticulum marker (calnexin) in hfNCSC-sEVs. (D) Nanoparticle tracking analysis was used to quantify the concentration and size distribution of hfNCSC-sEVs. (E) Transmission electron microscopy was used to visualize the characteristic morphology of hfNCSC-sEVs. (F) Immunofluorescence staining indicated that the third-generation PCs cultured in vitro were positive for claudin-1, zonula occludens 1 (ZO1), and glucose transporter 1 (GLUT1) but negative for S100, with DAPI staining marking the nuclei. (G) The internalization of PKH26-labeled hfNCSC-sEVs (red) by ZO1-positive PCs (green) was visualized using immunofluorescence staining, with DAPI staining to mark the nuclei. (H) The Cell Counting Kit-8 assay was used to evaluate the cell viability of PCs across concentrations of 0, 2 × 10 8 , 5 × 10 8 , and 10 × 10 8 particles/mL hfNCSC-sEVs at 3, 5, and 7 days of in vitro culture ( n = 5 per group). (I) The Transwell assay was used to quantify the number of migrating PCs at 6, 12, and 18 hours post-treatment with the aforementioned concentrations of hfNCSC-sEVs, in in vitro culture ( n = 6 per group). (J) Western blot and (K) statistical analyses revealed the relative protein expression levels of proliferating cell nuclear antigen <t>(PCNA)</t> and vimentin in PCs from the phosphate-buffered saline (PBS) and hfNCSC-sEVs groups on day 5 of in vitro culture (normalized to β-actin, n = 3 per group). Data are expressed as the mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001 (one-way analysis of variance and Tukey’s multiple comparison test for H and I; Student’s t -test for K). The data were from at least three separate and independent studies. CCK-8: Cell counting kit-8; GLUT1: glucose transporter 1; hfNCSCs: hair follicle neural crest stem cells; ns: not significant; PCNA: proliferating cell nuclear antigen; PCs: perineurial cells; sEVs: small extracellular vesicles; ZO1: zonula occludens 1.
    Rabbit Monoclonal Anti Proliferating Cell Nuclear Antigen Pcna, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit monoclonal anti proliferating cell nuclear antigen pcna/product/Proteintech
    Average 96 stars, based on 1 article reviews
    rabbit monoclonal anti proliferating cell nuclear antigen pcna - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    96
    Proteintech cell nuclear antigen pcna
    FGF4 alleviated the damage of lung cells caused by hyperglycemia. (A) Cell proliferation is promoted by FGF4 treatment. (B) The effect of FGF4 on the expression <t>of</t> <t>cyclinD1</t> and <t>PCNA</t> in cells. (C) The effect of FGF4 on the expression of p21 and p53. * P<0.05, ** P<0.01, *** P<0.001. FGF4, fibroblast growth factor 4; PCNA, proliferating cell nuclear antigen.
    Cell Nuclear Antigen Pcna, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cell nuclear antigen pcna/product/Proteintech
    Average 96 stars, based on 1 article reviews
    cell nuclear antigen pcna - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    96
    Proteintech anti proliferating cell nuclear antigen pcna antibody
    ( A ) Schematic illustration of cytoplasmic relocalization of p65 mediated by the anchoring aptamer. ( B ) Schematic diagram of the p65 ligand (P028F4, an aptamer targeting p65), the Ras ligand (Ra1, an aptamer targeting Ras) and anchoring aptamers [PAR (P028F4-AAA-Ra1), RAP (Ra1-AAA-P028F4), PTR (P028F4-TTT-Ra1), and RTP (Ra1-TTT-P028F4)]. ( C ) Native polyacrylamide gel analysis of aptamers. Lane 1, single-stranded DNA (ssDNA) marker; lane 2, P028F4; lane 3, Ra1; lane 4, PAR; lane 5, RAP; lane 6, PTR; lane 7, RTP. nt, nucleotides. ( D ) H1299 cells were transfected with control library, PAR, RAP, PTR, or RTP (all at 200 nM) for 12 hours, followed by tumor necrosis factor–α (TNFα) stimulation (10 ng/ml for 1.5 hours). Cytoplasmic (cyto) and nuclear (nuc) p65 levels were analyzed by cellular fractionation and immunoblotting. Error bars represent means ± SD from three independent experiments ( n = 3). P values are indicated by Student’s t test. ( E ) H1299 cells were transfected with 200 nM RTP constructs containing linkers of different lengths for 12 hours, followed by TNFα stimulation (10 ng/ml for 1.5 hours). Cytoplasmic and nuclear p65 levels were analyzed by cellular fractionation and immunoblotting. ( F ) H1299 cells were transfected with RTP at varying concentrations (0, 100, 200, and 300 nM) for 12 hours, followed by TNFα stimulation (10 ng/ml for 1.5 hours). Cytoplasmic and nuclear p65 levels were assessed by cellular fractionation and immunoblotting. <t>Proliferating</t> cell nuclear antigen <t>(PCNA)</t> or H3 serves as the nuclear marker, and β-actin or vinculin serves as the cytoplasmic marker.
    Anti Proliferating Cell Nuclear Antigen Pcna Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti proliferating cell nuclear antigen pcna antibody/product/Proteintech
    Average 96 stars, based on 1 article reviews
    anti proliferating cell nuclear antigen pcna antibody - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    95
    Boster Bio anti proliferating cell nuclear antigen pcna antibody
    ( A ) Schematic illustration of cytoplasmic relocalization of p65 mediated by the anchoring aptamer. ( B ) Schematic diagram of the p65 ligand (P028F4, an aptamer targeting p65), the Ras ligand (Ra1, an aptamer targeting Ras) and anchoring aptamers [PAR (P028F4-AAA-Ra1), RAP (Ra1-AAA-P028F4), PTR (P028F4-TTT-Ra1), and RTP (Ra1-TTT-P028F4)]. ( C ) Native polyacrylamide gel analysis of aptamers. Lane 1, single-stranded DNA (ssDNA) marker; lane 2, P028F4; lane 3, Ra1; lane 4, PAR; lane 5, RAP; lane 6, PTR; lane 7, RTP. nt, nucleotides. ( D ) H1299 cells were transfected with control library, PAR, RAP, PTR, or RTP (all at 200 nM) for 12 hours, followed by tumor necrosis factor–α (TNFα) stimulation (10 ng/ml for 1.5 hours). Cytoplasmic (cyto) and nuclear (nuc) p65 levels were analyzed by cellular fractionation and immunoblotting. Error bars represent means ± SD from three independent experiments ( n = 3). P values are indicated by Student’s t test. ( E ) H1299 cells were transfected with 200 nM RTP constructs containing linkers of different lengths for 12 hours, followed by TNFα stimulation (10 ng/ml for 1.5 hours). Cytoplasmic and nuclear p65 levels were analyzed by cellular fractionation and immunoblotting. ( F ) H1299 cells were transfected with RTP at varying concentrations (0, 100, 200, and 300 nM) for 12 hours, followed by TNFα stimulation (10 ng/ml for 1.5 hours). Cytoplasmic and nuclear p65 levels were assessed by cellular fractionation and immunoblotting. <t>Proliferating</t> cell nuclear antigen <t>(PCNA)</t> or H3 serves as the nuclear marker, and β-actin or vinculin serves as the cytoplasmic marker.
    Anti Proliferating Cell Nuclear Antigen Pcna Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti proliferating cell nuclear antigen pcna antibody/product/Boster Bio
    Average 95 stars, based on 1 article reviews
    anti proliferating cell nuclear antigen pcna antibody - by Bioz Stars, 2026-02
    95/100 stars
      Buy from Supplier

    96
    Proteintech proliferation cell nuclear antigen
    ( A ) Schematic illustration of cytoplasmic relocalization of p65 mediated by the anchoring aptamer. ( B ) Schematic diagram of the p65 ligand (P028F4, an aptamer targeting p65), the Ras ligand (Ra1, an aptamer targeting Ras) and anchoring aptamers [PAR (P028F4-AAA-Ra1), RAP (Ra1-AAA-P028F4), PTR (P028F4-TTT-Ra1), and RTP (Ra1-TTT-P028F4)]. ( C ) Native polyacrylamide gel analysis of aptamers. Lane 1, single-stranded DNA (ssDNA) marker; lane 2, P028F4; lane 3, Ra1; lane 4, PAR; lane 5, RAP; lane 6, PTR; lane 7, RTP. nt, nucleotides. ( D ) H1299 cells were transfected with control library, PAR, RAP, PTR, or RTP (all at 200 nM) for 12 hours, followed by tumor necrosis factor–α (TNFα) stimulation (10 ng/ml for 1.5 hours). Cytoplasmic (cyto) and nuclear (nuc) p65 levels were analyzed by cellular fractionation and immunoblotting. Error bars represent means ± SD from three independent experiments ( n = 3). P values are indicated by Student’s t test. ( E ) H1299 cells were transfected with 200 nM RTP constructs containing linkers of different lengths for 12 hours, followed by TNFα stimulation (10 ng/ml for 1.5 hours). Cytoplasmic and nuclear p65 levels were analyzed by cellular fractionation and immunoblotting. ( F ) H1299 cells were transfected with RTP at varying concentrations (0, 100, 200, and 300 nM) for 12 hours, followed by TNFα stimulation (10 ng/ml for 1.5 hours). Cytoplasmic and nuclear p65 levels were assessed by cellular fractionation and immunoblotting. <t>Proliferating</t> cell nuclear antigen <t>(PCNA)</t> or H3 serves as the nuclear marker, and β-actin or vinculin serves as the cytoplasmic marker.
    Proliferation Cell Nuclear Antigen, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/proliferation cell nuclear antigen/product/Proteintech
    Average 96 stars, based on 1 article reviews
    proliferation cell nuclear antigen - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    96
    Proteintech anti proliferating cell nuclear antigen
    ( A ) Schematic illustration of cytoplasmic relocalization of p65 mediated by the anchoring aptamer. ( B ) Schematic diagram of the p65 ligand (P028F4, an aptamer targeting p65), the Ras ligand (Ra1, an aptamer targeting Ras) and anchoring aptamers [PAR (P028F4-AAA-Ra1), RAP (Ra1-AAA-P028F4), PTR (P028F4-TTT-Ra1), and RTP (Ra1-TTT-P028F4)]. ( C ) Native polyacrylamide gel analysis of aptamers. Lane 1, single-stranded DNA (ssDNA) marker; lane 2, P028F4; lane 3, Ra1; lane 4, PAR; lane 5, RAP; lane 6, PTR; lane 7, RTP. nt, nucleotides. ( D ) H1299 cells were transfected with control library, PAR, RAP, PTR, or RTP (all at 200 nM) for 12 hours, followed by tumor necrosis factor–α (TNFα) stimulation (10 ng/ml for 1.5 hours). Cytoplasmic (cyto) and nuclear (nuc) p65 levels were analyzed by cellular fractionation and immunoblotting. Error bars represent means ± SD from three independent experiments ( n = 3). P values are indicated by Student’s t test. ( E ) H1299 cells were transfected with 200 nM RTP constructs containing linkers of different lengths for 12 hours, followed by TNFα stimulation (10 ng/ml for 1.5 hours). Cytoplasmic and nuclear p65 levels were analyzed by cellular fractionation and immunoblotting. ( F ) H1299 cells were transfected with RTP at varying concentrations (0, 100, 200, and 300 nM) for 12 hours, followed by TNFα stimulation (10 ng/ml for 1.5 hours). Cytoplasmic and nuclear p65 levels were assessed by cellular fractionation and immunoblotting. <t>Proliferating</t> cell nuclear antigen <t>(PCNA)</t> or H3 serves as the nuclear marker, and β-actin or vinculin serves as the cytoplasmic marker.
    Anti Proliferating Cell Nuclear Antigen, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti proliferating cell nuclear antigen/product/Proteintech
    Average 96 stars, based on 1 article reviews
    anti proliferating cell nuclear antigen - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    96
    Proteintech cell nuclear antigen pcna antibody
    ( A ) Schematic illustration of cytoplasmic relocalization of p65 mediated by the anchoring aptamer. ( B ) Schematic diagram of the p65 ligand (P028F4, an aptamer targeting p65), the Ras ligand (Ra1, an aptamer targeting Ras) and anchoring aptamers [PAR (P028F4-AAA-Ra1), RAP (Ra1-AAA-P028F4), PTR (P028F4-TTT-Ra1), and RTP (Ra1-TTT-P028F4)]. ( C ) Native polyacrylamide gel analysis of aptamers. Lane 1, single-stranded DNA (ssDNA) marker; lane 2, P028F4; lane 3, Ra1; lane 4, PAR; lane 5, RAP; lane 6, PTR; lane 7, RTP. nt, nucleotides. ( D ) H1299 cells were transfected with control library, PAR, RAP, PTR, or RTP (all at 200 nM) for 12 hours, followed by tumor necrosis factor–α (TNFα) stimulation (10 ng/ml for 1.5 hours). Cytoplasmic (cyto) and nuclear (nuc) p65 levels were analyzed by cellular fractionation and immunoblotting. Error bars represent means ± SD from three independent experiments ( n = 3). P values are indicated by Student’s t test. ( E ) H1299 cells were transfected with 200 nM RTP constructs containing linkers of different lengths for 12 hours, followed by TNFα stimulation (10 ng/ml for 1.5 hours). Cytoplasmic and nuclear p65 levels were analyzed by cellular fractionation and immunoblotting. ( F ) H1299 cells were transfected with RTP at varying concentrations (0, 100, 200, and 300 nM) for 12 hours, followed by TNFα stimulation (10 ng/ml for 1.5 hours). Cytoplasmic and nuclear p65 levels were assessed by cellular fractionation and immunoblotting. <t>Proliferating</t> cell nuclear antigen <t>(PCNA)</t> or H3 serves as the nuclear marker, and β-actin or vinculin serves as the cytoplasmic marker.
    Cell Nuclear Antigen Pcna Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cell nuclear antigen pcna antibody/product/Proteintech
    Average 96 stars, based on 1 article reviews
    cell nuclear antigen pcna antibody - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    Image Search Results


    hfNCSC-sEVs are taken up by PCs in vitro and enhance their proliferation and migration. (A) Primary cultures of hfNCSCs were established from male Sprague–Dawley rats. (B) Immunofluorescence staining of the neural crest cell marker p75 (red) and the stem cell marker nestin (green) in hfNCSCs, with 4′,6-diamidino-2-phenylindole (DAPI) staining indicating the nuclei. (C) Western blot analysis demonstrated the presence of surface markers (cluster of differentiation [CD]9, CD81, and tumor susceptibility gene 101 protein [TSG101]) and the absence of an endoplasmic reticulum marker (calnexin) in hfNCSC-sEVs. (D) Nanoparticle tracking analysis was used to quantify the concentration and size distribution of hfNCSC-sEVs. (E) Transmission electron microscopy was used to visualize the characteristic morphology of hfNCSC-sEVs. (F) Immunofluorescence staining indicated that the third-generation PCs cultured in vitro were positive for claudin-1, zonula occludens 1 (ZO1), and glucose transporter 1 (GLUT1) but negative for S100, with DAPI staining marking the nuclei. (G) The internalization of PKH26-labeled hfNCSC-sEVs (red) by ZO1-positive PCs (green) was visualized using immunofluorescence staining, with DAPI staining to mark the nuclei. (H) The Cell Counting Kit-8 assay was used to evaluate the cell viability of PCs across concentrations of 0, 2 × 10 8 , 5 × 10 8 , and 10 × 10 8 particles/mL hfNCSC-sEVs at 3, 5, and 7 days of in vitro culture ( n = 5 per group). (I) The Transwell assay was used to quantify the number of migrating PCs at 6, 12, and 18 hours post-treatment with the aforementioned concentrations of hfNCSC-sEVs, in in vitro culture ( n = 6 per group). (J) Western blot and (K) statistical analyses revealed the relative protein expression levels of proliferating cell nuclear antigen (PCNA) and vimentin in PCs from the phosphate-buffered saline (PBS) and hfNCSC-sEVs groups on day 5 of in vitro culture (normalized to β-actin, n = 3 per group). Data are expressed as the mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001 (one-way analysis of variance and Tukey’s multiple comparison test for H and I; Student’s t -test for K). The data were from at least three separate and independent studies. CCK-8: Cell counting kit-8; GLUT1: glucose transporter 1; hfNCSCs: hair follicle neural crest stem cells; ns: not significant; PCNA: proliferating cell nuclear antigen; PCs: perineurial cells; sEVs: small extracellular vesicles; ZO1: zonula occludens 1.

    Journal: Neural Regeneration Research

    Article Title: Small extracellular vesicles derived from hair follicle neural crest stem cells enhance perineurial cell proliferation and migration via the TGF-β/SMAD/HAS2 pathway

    doi: 10.4103/NRR.NRR-D-25-00127

    Figure Lengend Snippet: hfNCSC-sEVs are taken up by PCs in vitro and enhance their proliferation and migration. (A) Primary cultures of hfNCSCs were established from male Sprague–Dawley rats. (B) Immunofluorescence staining of the neural crest cell marker p75 (red) and the stem cell marker nestin (green) in hfNCSCs, with 4′,6-diamidino-2-phenylindole (DAPI) staining indicating the nuclei. (C) Western blot analysis demonstrated the presence of surface markers (cluster of differentiation [CD]9, CD81, and tumor susceptibility gene 101 protein [TSG101]) and the absence of an endoplasmic reticulum marker (calnexin) in hfNCSC-sEVs. (D) Nanoparticle tracking analysis was used to quantify the concentration and size distribution of hfNCSC-sEVs. (E) Transmission electron microscopy was used to visualize the characteristic morphology of hfNCSC-sEVs. (F) Immunofluorescence staining indicated that the third-generation PCs cultured in vitro were positive for claudin-1, zonula occludens 1 (ZO1), and glucose transporter 1 (GLUT1) but negative for S100, with DAPI staining marking the nuclei. (G) The internalization of PKH26-labeled hfNCSC-sEVs (red) by ZO1-positive PCs (green) was visualized using immunofluorescence staining, with DAPI staining to mark the nuclei. (H) The Cell Counting Kit-8 assay was used to evaluate the cell viability of PCs across concentrations of 0, 2 × 10 8 , 5 × 10 8 , and 10 × 10 8 particles/mL hfNCSC-sEVs at 3, 5, and 7 days of in vitro culture ( n = 5 per group). (I) The Transwell assay was used to quantify the number of migrating PCs at 6, 12, and 18 hours post-treatment with the aforementioned concentrations of hfNCSC-sEVs, in in vitro culture ( n = 6 per group). (J) Western blot and (K) statistical analyses revealed the relative protein expression levels of proliferating cell nuclear antigen (PCNA) and vimentin in PCs from the phosphate-buffered saline (PBS) and hfNCSC-sEVs groups on day 5 of in vitro culture (normalized to β-actin, n = 3 per group). Data are expressed as the mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001 (one-way analysis of variance and Tukey’s multiple comparison test for H and I; Student’s t -test for K). The data were from at least three separate and independent studies. CCK-8: Cell counting kit-8; GLUT1: glucose transporter 1; hfNCSCs: hair follicle neural crest stem cells; ns: not significant; PCNA: proliferating cell nuclear antigen; PCs: perineurial cells; sEVs: small extracellular vesicles; ZO1: zonula occludens 1.

    Article Snippet: The following primary antibodies were used: rabbit monoclonal anti-proliferating cell nuclear antigen (PCNA) antibody (1:2000, Cat# 60097-1-Ig, Proteintech, Wuhan, China), rabbit monoclonal anti-vimentin antibody (1:1000, Cat# 5741, Cell Signaling Technology, Danvers, MA, USA), rabbit polyclonal anti-claudin-1 antibody (1:1000, Cat# 13050-1-AP, Proteintech), rabbit polyclonal anti-zonula occludens 1 (ZO1) antibody (1:10 000, Cat# 21773-1-AP, Proteintech), rabbit polyclonal anti-mothers against decapentaplegic homolog (SMAD)7 antibody (1:500, Cat# WL02975, Wanleibio, Shenyang, China), rabbit polyclonal anti-SMAD2/3 antibody (1:1000, Cat# WL01520, Wanleibio), rabbit polyclonal anti-p-SMAD2/3 antibody (1:500, Cat# WL02305, Wanleibio), rabbit recombinant anti-hyaluronan synthase 2 (HAS2) antibody (1:500, Cat# DF13702, Affinity, Cincinnati, OH, USA), rabbit monoclonal anti-β-actin antibody (1:1000, Cat# 4970, Cell Signaling Technology), and mouse monoclonal anti-β-tubulin antibody (1:5000, Cat# M20005 , Abmart, Shanghai, China).

    Techniques: In Vitro, Migration, Immunofluorescence, Staining, Marker, Western Blot, Concentration Assay, Transmission Assay, Electron Microscopy, Cell Culture, Labeling, Cell Counting, Transwell Assay, Expressing, Saline, Comparison, CCK-8 Assay

    miR-21-5p in hfNCSC-sEVs augments cell proliferation and migration by enhancing HAS2 expression in PCs. (A, B) Western blot (A) and statistical analyses (B) revealed the relative protein expression levels of HAS2, proliferating cell nuclear antigen (PCNA), and vimentin in PCs across the –/–, –/si- Has2 , hfNCSC-sEVs/–, and hfNCSC-sEVs/si- Has2 groups on day 5 of in vitro culture (normalized to β-actin, n = 3 per group). (C, D) The wound healing assay (C) and statistical analysis (D) demonstrated the migration rates of PCs in the aforementioned groups ( n = 3 per group). (E) The Cell Counting Kit-8 assay was used to assess cell viability in PCs across the same groups on day 5 of in vitro culture ( n = 5 per group). (F, G) Western blot (F) and statistical analyses (G) indicated the relative protein expression levels of HAS2, PCNA, and vimentin in PCs treated with phosphate-buffered saline (PBS), hfNCSC-sEVs, or hfNCSC-sEVs + miR-21-5p inhibitor on day 5 of in vitro culture (normalized to β-actin, n = 3 per group). (H–J) Immunofluorescence staining visualized the expression of HAS2 (red) and 5-ethynyl-2′-deoxyuridine (EdU; green) in PCs (H), and statistical analysis revealed the integrated optical density (IOD) of zonula occludens 1 (ZO1; I) and the cell proliferation rates (J) in the PBS, hfNCSC-sEVs, and hfNCSC-sEVs + miR-21-5p inhibitor groups on day 5 of in vitro culture ( n = 3 per group). (K, L) Western blot (K) and statistical analyses (L) showed the relative protein expression levels of HAS2, PCNA, and vimentin in regenerated tissue from the PBS, hfNCSC-sEVs, and hfNCSC-sEVs + miR-21-5p inhibitor groups on day 5 post-operation (normalized to β-tubulin, n = 3 per group). Data are expressed as the mean ± SEM. ** P < 0.01, *** P < 0.001 (one-way analysis of variance and Tukey’s multiple comparison test for B, D, E, G, I, J, and L). The data were from at least three separate and independent studies. CCK-8: Cell counting kit-8; EdU: 5-ethynyl-2′-deoxyuridine; HAS2: hyaluronan synthase 2; hfNCSCs: hair follicle neural crest stem cells; IOD: integrated optical density; PCNA: proliferating cell nuclear antigen; PCs: perineurial cells; sEVs: small extracellular vesicles; ZO1: zonula occludens 1.

    Journal: Neural Regeneration Research

    Article Title: Small extracellular vesicles derived from hair follicle neural crest stem cells enhance perineurial cell proliferation and migration via the TGF-β/SMAD/HAS2 pathway

    doi: 10.4103/NRR.NRR-D-25-00127

    Figure Lengend Snippet: miR-21-5p in hfNCSC-sEVs augments cell proliferation and migration by enhancing HAS2 expression in PCs. (A, B) Western blot (A) and statistical analyses (B) revealed the relative protein expression levels of HAS2, proliferating cell nuclear antigen (PCNA), and vimentin in PCs across the –/–, –/si- Has2 , hfNCSC-sEVs/–, and hfNCSC-sEVs/si- Has2 groups on day 5 of in vitro culture (normalized to β-actin, n = 3 per group). (C, D) The wound healing assay (C) and statistical analysis (D) demonstrated the migration rates of PCs in the aforementioned groups ( n = 3 per group). (E) The Cell Counting Kit-8 assay was used to assess cell viability in PCs across the same groups on day 5 of in vitro culture ( n = 5 per group). (F, G) Western blot (F) and statistical analyses (G) indicated the relative protein expression levels of HAS2, PCNA, and vimentin in PCs treated with phosphate-buffered saline (PBS), hfNCSC-sEVs, or hfNCSC-sEVs + miR-21-5p inhibitor on day 5 of in vitro culture (normalized to β-actin, n = 3 per group). (H–J) Immunofluorescence staining visualized the expression of HAS2 (red) and 5-ethynyl-2′-deoxyuridine (EdU; green) in PCs (H), and statistical analysis revealed the integrated optical density (IOD) of zonula occludens 1 (ZO1; I) and the cell proliferation rates (J) in the PBS, hfNCSC-sEVs, and hfNCSC-sEVs + miR-21-5p inhibitor groups on day 5 of in vitro culture ( n = 3 per group). (K, L) Western blot (K) and statistical analyses (L) showed the relative protein expression levels of HAS2, PCNA, and vimentin in regenerated tissue from the PBS, hfNCSC-sEVs, and hfNCSC-sEVs + miR-21-5p inhibitor groups on day 5 post-operation (normalized to β-tubulin, n = 3 per group). Data are expressed as the mean ± SEM. ** P < 0.01, *** P < 0.001 (one-way analysis of variance and Tukey’s multiple comparison test for B, D, E, G, I, J, and L). The data were from at least three separate and independent studies. CCK-8: Cell counting kit-8; EdU: 5-ethynyl-2′-deoxyuridine; HAS2: hyaluronan synthase 2; hfNCSCs: hair follicle neural crest stem cells; IOD: integrated optical density; PCNA: proliferating cell nuclear antigen; PCs: perineurial cells; sEVs: small extracellular vesicles; ZO1: zonula occludens 1.

    Article Snippet: The following primary antibodies were used: rabbit monoclonal anti-proliferating cell nuclear antigen (PCNA) antibody (1:2000, Cat# 60097-1-Ig, Proteintech, Wuhan, China), rabbit monoclonal anti-vimentin antibody (1:1000, Cat# 5741, Cell Signaling Technology, Danvers, MA, USA), rabbit polyclonal anti-claudin-1 antibody (1:1000, Cat# 13050-1-AP, Proteintech), rabbit polyclonal anti-zonula occludens 1 (ZO1) antibody (1:10 000, Cat# 21773-1-AP, Proteintech), rabbit polyclonal anti-mothers against decapentaplegic homolog (SMAD)7 antibody (1:500, Cat# WL02975, Wanleibio, Shenyang, China), rabbit polyclonal anti-SMAD2/3 antibody (1:1000, Cat# WL01520, Wanleibio), rabbit polyclonal anti-p-SMAD2/3 antibody (1:500, Cat# WL02305, Wanleibio), rabbit recombinant anti-hyaluronan synthase 2 (HAS2) antibody (1:500, Cat# DF13702, Affinity, Cincinnati, OH, USA), rabbit monoclonal anti-β-actin antibody (1:1000, Cat# 4970, Cell Signaling Technology), and mouse monoclonal anti-β-tubulin antibody (1:5000, Cat# M20005 , Abmart, Shanghai, China).

    Techniques: Migration, Expressing, Western Blot, In Vitro, Wound Healing Assay, Cell Counting, Saline, Immunofluorescence, Staining, Comparison, CCK-8 Assay

    FGF4 alleviated the damage of lung cells caused by hyperglycemia. (A) Cell proliferation is promoted by FGF4 treatment. (B) The effect of FGF4 on the expression of cyclinD1 and PCNA in cells. (C) The effect of FGF4 on the expression of p21 and p53. * P<0.05, ** P<0.01, *** P<0.001. FGF4, fibroblast growth factor 4; PCNA, proliferating cell nuclear antigen.

    Journal: International Journal of Molecular Medicine

    Article Title: FGF4 alleviates the lung cell damage caused by high glucose via AMPK-PGC-1 signaling axis in vitro and in vivo

    doi: 10.3892/ijmm.2025.5710

    Figure Lengend Snippet: FGF4 alleviated the damage of lung cells caused by hyperglycemia. (A) Cell proliferation is promoted by FGF4 treatment. (B) The effect of FGF4 on the expression of cyclinD1 and PCNA in cells. (C) The effect of FGF4 on the expression of p21 and p53. * P<0.05, ** P<0.01, *** P<0.001. FGF4, fibroblast growth factor 4; PCNA, proliferating cell nuclear antigen.

    Article Snippet: CyclinD1, proliferating cell nuclear antigen (PCNA), phosphorylated (p-)IκB, p-P65 and p-STAT3 were from Proteintech Group, Inc. malondialdehyde (MDA; cat. no. A003-1-2), SOD (cat. no. A001-3-2) and glutathione peroxidase (GPX; cat. no. H545-1-1) were from Nanjing Jiancheng Bioengineering Institute.

    Techniques: Expressing

    ( A ) Schematic illustration of cytoplasmic relocalization of p65 mediated by the anchoring aptamer. ( B ) Schematic diagram of the p65 ligand (P028F4, an aptamer targeting p65), the Ras ligand (Ra1, an aptamer targeting Ras) and anchoring aptamers [PAR (P028F4-AAA-Ra1), RAP (Ra1-AAA-P028F4), PTR (P028F4-TTT-Ra1), and RTP (Ra1-TTT-P028F4)]. ( C ) Native polyacrylamide gel analysis of aptamers. Lane 1, single-stranded DNA (ssDNA) marker; lane 2, P028F4; lane 3, Ra1; lane 4, PAR; lane 5, RAP; lane 6, PTR; lane 7, RTP. nt, nucleotides. ( D ) H1299 cells were transfected with control library, PAR, RAP, PTR, or RTP (all at 200 nM) for 12 hours, followed by tumor necrosis factor–α (TNFα) stimulation (10 ng/ml for 1.5 hours). Cytoplasmic (cyto) and nuclear (nuc) p65 levels were analyzed by cellular fractionation and immunoblotting. Error bars represent means ± SD from three independent experiments ( n = 3). P values are indicated by Student’s t test. ( E ) H1299 cells were transfected with 200 nM RTP constructs containing linkers of different lengths for 12 hours, followed by TNFα stimulation (10 ng/ml for 1.5 hours). Cytoplasmic and nuclear p65 levels were analyzed by cellular fractionation and immunoblotting. ( F ) H1299 cells were transfected with RTP at varying concentrations (0, 100, 200, and 300 nM) for 12 hours, followed by TNFα stimulation (10 ng/ml for 1.5 hours). Cytoplasmic and nuclear p65 levels were assessed by cellular fractionation and immunoblotting. Proliferating cell nuclear antigen (PCNA) or H3 serves as the nuclear marker, and β-actin or vinculin serves as the cytoplasmic marker.

    Journal: Science Advances

    Article Title: Engineered anchoring aptamers induce relocalization and functional inactivation of transcription factors

    doi: 10.1126/sciadv.adw6496

    Figure Lengend Snippet: ( A ) Schematic illustration of cytoplasmic relocalization of p65 mediated by the anchoring aptamer. ( B ) Schematic diagram of the p65 ligand (P028F4, an aptamer targeting p65), the Ras ligand (Ra1, an aptamer targeting Ras) and anchoring aptamers [PAR (P028F4-AAA-Ra1), RAP (Ra1-AAA-P028F4), PTR (P028F4-TTT-Ra1), and RTP (Ra1-TTT-P028F4)]. ( C ) Native polyacrylamide gel analysis of aptamers. Lane 1, single-stranded DNA (ssDNA) marker; lane 2, P028F4; lane 3, Ra1; lane 4, PAR; lane 5, RAP; lane 6, PTR; lane 7, RTP. nt, nucleotides. ( D ) H1299 cells were transfected with control library, PAR, RAP, PTR, or RTP (all at 200 nM) for 12 hours, followed by tumor necrosis factor–α (TNFα) stimulation (10 ng/ml for 1.5 hours). Cytoplasmic (cyto) and nuclear (nuc) p65 levels were analyzed by cellular fractionation and immunoblotting. Error bars represent means ± SD from three independent experiments ( n = 3). P values are indicated by Student’s t test. ( E ) H1299 cells were transfected with 200 nM RTP constructs containing linkers of different lengths for 12 hours, followed by TNFα stimulation (10 ng/ml for 1.5 hours). Cytoplasmic and nuclear p65 levels were analyzed by cellular fractionation and immunoblotting. ( F ) H1299 cells were transfected with RTP at varying concentrations (0, 100, 200, and 300 nM) for 12 hours, followed by TNFα stimulation (10 ng/ml for 1.5 hours). Cytoplasmic and nuclear p65 levels were assessed by cellular fractionation and immunoblotting. Proliferating cell nuclear antigen (PCNA) or H3 serves as the nuclear marker, and β-actin or vinculin serves as the cytoplasmic marker.

    Article Snippet: The anti-Ras antibody (18295-1-AP), anti-E2F1 antibody (66515-1-Ig), anti-vinculin antibody (66305-2-Ig), anti-H3 antibody (68345-1-Ig), and anti-proliferating cell nuclear antigen (PCNA) antibody (60097-1-Ig) were obtained from Proteintech.

    Techniques: Marker, Transfection, Control, Cell Fractionation, Western Blot, Construct